A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm3

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 5, 2009, Pages 279-285

  Mani, Deepthi ^a   Neil, Nancy ^b   Israel, Rebecca ^c   Aboulafia, David M ^c  

^a Spokane Medical Centers   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

CD4 counts >cells mm3; HIV; Kaposi's sarcoma; undetectable HIV viral loads

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; KAPOSI SARCOMA; LYMPH NODE; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; SKIN NEOPLASMS; VIRAL LOAD;

EID: 75349103707     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709341852     Document Type: Article

References (32)

1. Centers for Disease Control (CDC). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep. 1981 ; 30 (25). 305-308.
2. Friedman-Kien AE Disseminated Kaposi 's sarcoma syndrome in young homos (Pubitemid 12247094)
3. Goedert JJ Epidemiology of acquired immune deficiency syndrome malignancies. Semon Oncol. 2000 ; 27 (4). 390-401. (Pubitemid 30626437)
4. Cattelan AM, Calabro ML, DeRossi A., et al. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy. Int J Oncol. 2005 ; 27 (3). 779-785.
5. Portsmouth S., Stebbing J., Gill J., et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS. 2003 ;17 (11). F17 - F22.
6. Yarchoan R., Tosato G., Little RF Therapy insight: AIDS-related malignancies-the influence of antiviral therapy on pathogenesis and management. Nat Clin Prat Oncol. 2005 ; 2 (8). 406-415. (Pubitemid 43115009)
7. Di Lorenzo G., Konstantinopoulos PA, Pantanowitz L., et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007 ; 8 (2). 167-176. (Pubitemid 46158383)
8. Cattelan AM, Calabro ML, Aversa SM, et al. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome. Eur J Cancer. 1999 ; 35 (13). 1809-1815. (Pubitemid 29512313)
9. Patel P., Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008 ; 148 (10). 728-736. (Pubitemid 351717418)
10. Mocroft A., Kirk O., Clumek N., et al. The changing pattern of Kaposi's sarcoma in patients with HIV, 1994-2003: the Euro-SIDA study. Cancer. 2004 ; 100 (12). 2644-2654. (Pubitemid 38715771)
11. Masys DR, Feng F., Ye I., et al. Preliminary findings on cancer incidents in HIV-infected persons from six countries in Central and South America and the Caribbean. 11th Int Conference on Malignancies and AIDS and Other Acquired Immunodeficiencies, Bethesda, MD, Oct 6-7, 2008, Abstract 047.
12. Parkin DM The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006 ; 118 (12). 3030-3044.
13. Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 ; 23 (6). 1253-1260. (Pubitemid 46202283)
14. Maurer T., Ponte M., Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med. 2007 ; 357 (13). 1352-1353. (Pubitemid 47481472)
15. Krown SE, Lee JY, Dittmer DP the AIDS Malignancy Consortium. More on HIV-associated Kaposi's sarcoma. N Engl J Med. 2008 ; 358 (5). 535-536. (Pubitemid 351185822)
16. Stebbing J., Powles T., Bower M. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count. AIDS. 2008 ; 22 (4). 551-552. (Pubitemid 351317307)
17. Krown SE, Testa MA, Huang J. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997 ; 15 (9). 3085-3092. (Pubitemid 27377500)
18. Krown SE, Metroka C., Wernz JC Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989 ; 7 (9). 1201-1207. (Pubitemid 19220121)
19. Nasti G., Martellotta F., Berretta M., et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer. 2003 ; 98 (11). 2440-2446. (Pubitemid 37466659)
20. El Amari EB, Toutous-Trellu L., Gayet-Ageron A., et al. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS. 2008 ; 22 (9). 1019-1028.
21. Martinez V., Caumes E., Gambotti L., et al. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer. 2006 ; 94 (7). 1000-1006.
22. Crum-Cianflone NF Immune reconstitution inflammatory syndrome: what's new? AIDS Read. 2006 ; 16 (4). 199-206, 213, 216-217.
23. Leidner RS, Aboulafia DM Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS. 2005 ; 19 (10). 635-644. (Pubitemid 41527674)
24. Bower M., Nelson M., Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol. 2005 ; 23 (22). 5224-5228. (Pubitemid 46224033)
25. Martin JN, Laker M., Cambua A., et al. Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation. 11th Int Conference on Malignancies and AIDS and Other Acquired Immunodeficiencies, Bethesda, MD, Oct 6-7, 2008, Abstract 046.
26. Dupin N., Dell Giudice T. Editorial commentary: treatment of Kaposi's sarcoma in the highly active antiretroviral therapy era. Clin Infec Dis. 2008 ; 47 (3). 418-420. (Pubitemid 352009366)
27. Nguyen HQ, Magaret AS, Kitahata MM, Van Rompay SE, Walt A., Casper C. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS. 2008 ; 22 (8). 937-945. (Pubitemid 351652244)
28. Martín-Carbonero L., Palacios R., Valencia E., et al. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis. 2008 ; 47 (3). 410-417. (Pubitemid 352009365)
29. Quinlivan EB, Zhang C., Stewart PW, Kolmoltri C., Davis MG, Wehbie RS Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis. 2002 ; 185 (12). 1736-1744. (Pubitemid 34615467)
30. Pellet C., Chevret S., Blum L., et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol. 2001 ; 117 (4). 858-863. (Pubitemid 33001202)
31. Skalsky RL, Samols MA, Plaisance KB, et al. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007 ; 81 (23). 12836-12845. (Pubitemid 350156921)
32. Gottwein E., Mukherjee N., Sachse C., et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature. 2007 ; 450 (7172). 1096-1099. (Pubitemid 350273603)